Patents by Inventor Stephen Wolpe

Stephen Wolpe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMIDAZOQUINOLYL COMPOUNDS HAVING ANTI-INFLAMMATORY, ANTIFUNGAL, ANTIPARASITIC, AND ANTICANCER ACTIVITY
    Publication number: 20210163476
    Abstract: Amine compounds having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The compounds contain a monocyclic, bicyclic, or tricyclic aromatic ring having one, two, or three ring nitrogen atoms.
    Type: Application
    Filed: February 16, 2021
    Publication date: June 3, 2021
    Inventors: David Michael SIMPSON, Dennis Bryan ZERBY, Ming LU, Reid Warren VON BORSTEL, Rui LI, Julian READING, Stephen WOLPE
  • Aminoquinazoline compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity
    Patent number: 10934284
    Abstract: Amine compounds having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The compounds contain a monocyclic, bicyclic, or tricyclic aromatic ring having one, two, or three ring nitrogen atoms.
    Type: Grant
    Filed: February 26, 2019
    Date of Patent: March 2, 2021
    Assignee: Wellstat Therapeutics Corporation
    Inventors: David M. Simpson, Dennis Bryan Zerby, Ming Lu, Reid W. Von Borstel, Rui Li, Julian Reading, Stephen Wolpe
  • AMINOQUINAZOLINE COMPOUNDS HAVING ANTI-INFLAMMATORY, ANTIFUNGAL, ANTIPARASITIC, AND ANTICANCER ACTIVITY
    Publication number: 20190194193
    Abstract: Amine compounds having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The compounds contain a monocyclic, bicyclic, or tricyclic aromatic ring having one, two, or three ring nitrogen atoms.
    Type: Application
    Filed: February 26, 2019
    Publication date: June 27, 2019
    Inventors: David M. SIMPSON, Dennis Bryan ZERBY, Ming LU, Reid W. VON BORSTEL, Rui LI, Julian READING, Stephen WOLPE
  • AMINOQUINOLINE COMPOUNDS HAVING ANTICANCER ACTIVITY
    Publication number: 20180298000
    Abstract: Amine compounds having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The compounds contain a monocyclic, bicyclic, or tricyclic aromatic ring having one, two, or three ring nitrogen atoms.
    Type: Application
    Filed: June 22, 2018
    Publication date: October 18, 2018
    Inventors: David M. SIMPSON, Dennis Bryan ZERBY, Ming LU, Reid W. VON BORSTEL, Rui LI, Julian READING, Stephen WOLPE, Nureddin AMAN
  • Amine compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity
    Patent number: 10030015
    Abstract: Amine compounds having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The compounds contain a monocyclic, bicyclic, or tricyclic aromatic ring having one, two, or three ring nitrogen atoms.
    Type: Grant
    Filed: January 31, 2014
    Date of Patent: July 24, 2018
    Assignee: Wellstat Therapeutics Corporation
    Inventors: David M. Simpson, Dennis Bryan Zerby, Ming Lu, Reid W. von Borstel, Rui Li, Julian Reading, Stephen Wolpe, Nureddin Aman
  • AMINE COMPOUNDS HAVING ANTI-INFLAMMATORY, ANTIFUNGAL, ANTIPARASITIC, AND ANTICANCER ACTIVITY
    Publication number: 20150361077
    Abstract: Amine compounds having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The compounds contain a monocyclic, bicyclic, or tricyclic aromatic ring having one, two, or three ring nitrogen atoms.
    Type: Application
    Filed: January 31, 2014
    Publication date: December 17, 2015
    Inventors: David M. Simpson, Dennis Bryan Zerby, Ming LU, Reid W. von Borstel, Rui Li, Julian Reading, Stephen Wolpe, Nureddin Aman
  • COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
    Publication number: 20080015209
    Abstract: Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
    Type: Application
    Filed: August 20, 2007
    Publication date: January 17, 2008
    Applicant: WELLSTAT THERAPEUTICS CORPORATION
    Inventors: Shalini Sharma, Reid von Borstel, Kirvin Hodge, Michael Bamat, Stephen Wolpe
  • COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
    Publication number: 20070265323
    Abstract: Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
    Type: Application
    Filed: July 2, 2007
    Publication date: November 15, 2007
    Applicant: WELLSTAT THERAPEUTICS CORPORATION
    Inventors: Shalini Sharma, Reid von Borstel, Kirvin Hodge, Michael Bamat, Stephen Wolpe
  • COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
    Publication number: 20070265322
    Abstract: Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
    Type: Application
    Filed: July 2, 2007
    Publication date: November 15, 2007
    Applicant: WELLSTAT THERAPEUTICS CORPORATION
    Inventors: Shalini Sharma, Reid von Borstel, Kirvin Hodge, Michael Bamat, Stephen Wolpe
  • COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
    Publication number: 20070249696
    Abstract: Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
    Type: Application
    Filed: July 2, 2007
    Publication date: October 25, 2007
    Applicant: WELLSTAT THERAPEUTICS CORPORATION
    Inventors: Shalini Sharma, Reid von Borstel, Kirvin Hodge, Michael Bamat, Stephen Wolpe
  • COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
    Publication number: 20070249719
    Abstract: Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
    Type: Application
    Filed: July 2, 2007
    Publication date: October 25, 2007
    Applicant: WELLSTAT THERAPEUTICS CORPORATION
    Inventors: Shalini Sharma, Reid von Borstel, Kirvin Hodge, Michael Bamat, Stephen Wolpe
  • COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
    Publication number: 20070244172
    Abstract: Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
    Type: Application
    Filed: July 2, 2007
    Publication date: October 18, 2007
    Applicant: WELLSTAT THERAPEUTICS CORPORATION
    Inventors: Shalini Sharma, Reid von Borstel, Kirvin Hodge, Michael Bamat, Stephen Wolpe
  • COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
    Publication number: 20070244141
    Abstract: Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
    Type: Application
    Filed: July 2, 2007
    Publication date: October 18, 2007
    Applicant: WELLSTAT THERAPEUTICS CORPORATION
    Inventors: Shalini Sharma, Reid von Borstel, Kirvin Hodge, Michael Bamat, Stephen Wolpe
  • COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
    Publication number: 20070244171
    Abstract: Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
    Type: Application
    Filed: July 2, 2007
    Publication date: October 18, 2007
    Applicant: WELLSTAT THERAPEUTICS CORPORATION
    Inventors: Shalini Sharma, Reid von Borstel, Kirvin Hodge, Michael Bamat, Stephen Wolpe
  • COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
    Publication number: 20070105958
    Abstract: Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
    Type: Application
    Filed: September 27, 2006
    Publication date: May 10, 2007
    Applicant: WELLSTAT THERAPEUTICS CORPORATION
    Inventors: Shalini Sharma, Reid von Borstel, Kirvin Hodge, Michael Bamat, Stephen Wolpe
  • Inhibitor and stimulator of stem cell proliferation and uses thereof
    Publication number: 20060166863
    Abstract: Disclosed and claimed are methods for the isolation and use of stem cell modulating factors for regulating stem cell cycle and for accelerating the post-chemotherapy peripheral blood cell recovery. Also disclosed and claimed are the inhibitors and stimulators of stem cell proliferation.
    Type: Application
    Filed: March 23, 2006
    Publication date: July 27, 2006
    Applicant: WELLSTAT THERAPEUTICS CORPORATION
    Inventors: Stephen Wolpe, Irena Tsyrlova
  • Compounds for the treatment of metabolic disorders
    Publication number: 20060035970
    Abstract: Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
    Type: Application
    Filed: October 28, 2003
    Publication date: February 16, 2006
    Inventors: Kirvin Hodge, Shalini Sharma, Reid Von Borstel, Stephen Wolpe
  • Compounds for the treatment of metabolic disorders
    Publication number: 20060014784
    Abstract: Agents useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyper-lipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis are disclosed.
    Type: Application
    Filed: April 8, 2004
    Publication date: January 19, 2006
    Inventors: Kirvin Hodge, Shalini Sharma, Reid Von Borstel, Stephen Wolpe
  • Inhibitor of stem cell proliferation and uses thereof
    Publication number: 20050043218
    Abstract: Disclosed and claimed are methods for the isolation and use of stem cell inhibiting factors for regulating the abnormal stem cell cycle and for accelerating the post-chemotherapy peripheral blood cell recovery. Also disclosed and claimed are the inhibitors of stem cell proliferation.
    Type: Application
    Filed: July 23, 2004
    Publication date: February 24, 2005
    Applicant: WELLSTAT THERAPEUTICS CORPORATION
    Inventors: Irena Tsyrlova, Stephen Wolpe